Open Philanthropy recommended an investment of $1,250,000 in Alvea. Alvea works on technology to reduce the time from concept to trials for new medicines, with the goal of accelerating treatments for infectious diseases and improving pandemic preparedness.
This follows our May 2022 investment and falls within Open Philanthropy’s focus area of biosecurity and pandemic preparedness.